SHELL ASSET MANAGEMENT CO - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$485,000
+57.0%
5,216
+0.5%
0.01%
+42.9%
Q3 2021$309,000
-49.0%
5,191
-34.2%
0.01%
-46.2%
Q4 2020$606,000
+2.7%
7,8840.0%0.01%
-7.1%
Q3 2020$590,000
+19.0%
7,8840.0%0.01%
+16.7%
Q2 2020$496,000
+48.5%
7,884
-0.8%
0.01%
+33.3%
Q1 2020$334,000
-8.7%
7,949
-1.5%
0.01%
+12.5%
Q4 2019$366,000
-2.9%
8,069
-1.9%
0.01%
-11.1%
Q3 2019$377,000
-22.4%
8,226
-0.8%
0.01%
-18.2%
Q2 2019$486,000
+27.9%
8,296
-2.2%
0.01%
+37.5%
Q1 2019$380,000
+15.2%
8,4850.0%0.01%0.0%
Q4 2018$330,000
-22.0%
8,485
-7.6%
0.01%0.0%
Q3 2018$423,0009,1850.01%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 505,670$34,487,0007.23%
Asymmetry Capital Management, L.P. 142,246$9,701,0006.67%
Prosight Management, LP 137,000$9,343,0005.84%
Avoro Capital Advisors LLC 4,075,000$277,915,0004.84%
Integral Health Asset Management, LLC 225,000$15,345,0004.22%
First Light Asset Management, LLC 617,124$42,088,0002.52%
SECTORAL ASSET MANAGEMENT INC 322,599$22,001,0001.78%
Avidity Partners Management LP 943,000$64,313,0001.74%
DAFNA Capital Management LLC 119,615$8,158,0001.71%
Nicholas Investment Partners, LP 298,247$20,340,0001.28%
View complete list of ARENA PHARMACEUTICALS INC shareholders